FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Delayed Deutsche Boerse AG 08:50:35 2024-06-18 EDT | ||
| 0.69 EUR | 0.00% |
|
| Current month | -4.17% | ||
| 1 month | -47.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
| Date | Price | Change |
|---|---|---|
| 24-06-18 | 0.69 | 0.00% |
| 24-06-17 | 0.69 | -8.00% |
| 24-06-14 | 0.75 | -1.32% |
| 24-06-13 | 0.76 | -17.39% |
| 24-06-12 | 0.92 | -6.12% |
Delayed Quote Deutsche Boerse AG
Last update June 18, 2024 at 08:50 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SU1H3R |
| ISIN | DE000SU1H3R4 |
| Date issued | 2023-11-02 |
| Strike | 51.48 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.34 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.38 € |
|---|---|
| Lowest since issue | 0.64 € |
| Spread | 0.02 € |
| Spread % | 2.82% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.97
USD
Average target price
53.19
USD
Spread / Average Target
+29.84%
- Stock Market
- Certificates
- Certificat
